Materials Healthcare Sector

Accuray

Market Cap: US$162.8m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

Puma Biotechnology

Market Cap: US$161.3m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Instil Bio

Market Cap: US$160.6m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

SELLAS Life Sciences Group

Market Cap: US$159.9m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Race Oncology

Market Cap: AU$246.7m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

Diaceutics

Market Cap: UK£117.9m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.

Journey Medical

Market Cap: US$157.6m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Prime Medicine

Market Cap: US$157.2m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

hVIVO

Market Cap: UK£115.7m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Profound Medical

Market Cap: CA$214.0m

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

EKF Diagnostics Holdings

Market Cap: UK£113.7m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

Joint

Market Cap: US$153.8m

Operates and franchises chiropractic clinics in the United States.

Wellgistics Health

Market Cap: US$152.8m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Cybin

Market Cap: US$152.7m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Tiziana Life Sciences

Market Cap: US$152.7m

A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

Kindly MD

Market Cap: US$150.2m

A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.

Longduoduo

Market Cap: US$149.8m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

Pro-Dex

Market Cap: US$148.8m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Prenetics Global

Market Cap: US$146.3m

A consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.

Avacta Group

Market Cap: UK£107.2m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

BioAge Labs

Market Cap: US$144.8m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Lucid Diagnostics

Market Cap: US$143.9m

Operates as a commercial-stage medical diagnostics technology company in the United States.

Liminatus Pharma

Market Cap: US$143.1m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

TerrAscend

Market Cap: CA$196.1m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Cogstate

Market Cap: AU$219.4m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

NeOnc Technologies Holdings

Market Cap: US$139.5m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Alpha Cognition

Market Cap: US$139.2m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

Korro Bio

Market Cap: US$139.1m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Lineage Cell Therapeutics

Market Cap: US$138.0m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Scancell Holdings

Market Cap: UK£101.7m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

Fate Therapeutics

Market Cap: US$137.6m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Compugen

Market Cap: US$137.5m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Inhibikase Therapeutics

Market Cap: US$136.8m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Aclaris Therapeutics

Market Cap: US$136.4m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

EUDA Health Holdings

Market Cap: US$136.4m

Operates as a healthcare specialty company.

Rapid Micro Biosystems

Market Cap: US$136.2m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.